WRAIR

Dr. David Mackenzie Rioch, a stem-faced, fundamentally benign man with dark bushy eyebrows, seemingly sensed that I might have been cast from a different mold. He was a relentlessly dedicated scientist who supervised my efforts at outpatient therapy for an hour each week. As civilian Chief of the Neuropsychiatry Division of the nearby Walter Reed Army Institute of Research (WRAIR), Rioch had a prestigious and well-earned international reputation. 

In 1969, we recommended long-term reevaluation of our subjects. But it wasn t until 1980 that LTC David McFarling at the Walter Reed Army Institute of Research (WRAIR) published a comprehensive follow-up of Edgewood volunteers who had received LSD. The results, discussed in detail later in this book, failed to demonstrate any clear-cut, long-term adverse medical or psychiatric effects. 

The Army didn t act to shield itself from further criticism until the mid-1970s, when Congress began to feel increasing pressure from critics. Only then, did its members request a systematic search for possible after effects in former LSD volunteers. Lieutenant Colonel David A. McFarling, MD, a psychiatrist assigned to the Walter Reed Army Institute of Research (WRAIR) in DC, accepted the task. He designed a comprehensive follow-up study of all volunteers who had received LSD under Chemical Corps auspices. In October 1980, the US Army Medical Department, US Army Health Services Command, published his report. 

As my time at Stanford was approaching an end, my old boss Joe Blair at Edgewood and my mentor David Rioch at the Walter Reed Army Institute of Research (WRAIR) simultaneously requested my assignment to their installations. Both apparently believed (incorrectly) that my competence had somehow been enhanced by my 24-month sojourn in the magic halls of academe. 

We would like to thank Drs. Robert Engle, Jean Karle, Dennis Kyle, Wil Milhous and Robert Miller of the Walter Reed Army Institute of Research for their advice and collaborations in preceding years, members of the Medicinal Chemistry Department (University of Mississippi), and Dr. James D. McChesney (NaPro Biotherapeutics). Support of this work was funded by the Department of Defense USAAMRDC (WRAIR), UNDPAVorld Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), NIAID, and the University of Mississippi Research Institute of Pharmaceutical Sciences. 

Institute of Research (WRAIR, Washington, DC). After finding that a chloroquine-resistant strain of P. berghei was deficient in a high-affinity receptor for the drug (Fitch, 1969,1970), he went on to identify FP as the receptor (Chou et ah, 1980 Fitch et al., 1974) later he found hemozoin to be dimerized FP similar to p-hematin (Fitch and Kanjananggulpan, 1987). Recently, he speculated that unsaturated fatty acids (FAs) and their mono- and diglycerides in the FV serve to concentrate the monomeric FP and keep it in a state favourable for dimerization (Fitch et al., 2003 Fitch and Russell, 2006). 

Coy Fitch (1934- ) as a medical student at the University of Arkansas School of Medicine (Little Rock, Arkansas), became interested in biochemistry and was provided research space and other resources. He earned an master of science (MS) in biochemistry as well as a doctor of medicine (MD) in 1958 and remained at the School of Medicine as a resident in medicine and Russell M. Wilder-National Vitamin Foundation Fellow in biochemistry (1958-1962). By the time the residency was completed he had developed an interest in membrane transport processes, and he remained on the faculty of the University of Arkansas as an assistant professor of medicine and biochemistry studying such. Five years later, he moved to the Saint Louis University School of Medicine (Saint Louis, Missouri) as Associate Professor of Internal Medicine and Biochemistry. That move made him vulnerable to military service. As a consequence, he was promptly drafted into the Army and assigned to the Division of Biochemistry of the WRAIR. 

F. WRAIR - CONUS assistance with diagnostic testing, disease pathogenesis, or treatment of patients with BW illnesses. 

US Army Medical Research Detachment at Brooks AFB can provide assistance in the medical effects, symptoms, and treatment of both laser and radiofrequency injuries. This detachment is part of Walter Reed Army Institute of Research (WRAIR). 

Walter Reed Army Institute of Research (WRAIR) NBC, Lasers, RF Army 8-10... 

Mission. The WRAIR s goal is to prevent illnesses and injuries, enhance human performance, and improve survivability on the battlefield. The Institute has produced many safe and effective drugs and vaccines, medical devices, diagnostic tests, and other much needed medical products, as well as obtained invaluable medical information that supports specific service policies. 

WRAIR - Walter Reed Army Institute of Research. 

Division of Experimental Therapeutics Department of Medicinal Chemistry Building 500, Room 3 Forest Glen, MD Fax 301-295-7755 Internet site wrair-www.army.mil/ wrair.htm... 

WRAIR Walter Reed Armv Institute of Research... 

---